본문 바로가기
KERD
논문KCI 등재

인후두 역류질환에서 양성자 펌프 억제제 치료가 삶의 질에 미치는 영향

Impact on Quality of Life after Treatment with Proton Pump Inhibitor in Laryngopharyngeal Reflux

정진혁|지용배|태경|전현웅|최해원|김무건
대한이비인후과학회 (Korean Society of Otorhinolaryngology-Head and Neck Surgery)|2020.11|대한이비인후과학회지 두경부외과학 (Korean Journal of Otorhinolaryngology-Head and Neck Surgery)|제63권 제11호|pp. 517-522|DOI https://doi.org/10.3342/kjorl-hns.2019.00899

4

조회

0

다운로드

1

인용

0

참고문헌

주제분류이비인후과학

초록

Background and Objectives Several studies have assessed the impact of laryngopharyngealreflux disease (LPRD) on the health-related quality of life (HR-QoL), showing significantimpairment of HR-QoL. This study aims to assess the impact of proton pump inhibitor (PPI)treatment of LPRDs to enhance HR-QoL. Subjects and Method We prospectively collected data from LPRD patients from April2017 to July 2019. Patients who have reflux symptom index (RSI) of ≥13 or reflux findingscore (RFS) of ≥7 were enrolled in this study. We assessed HR-QoL using a questionnairewith EORTC QLQ-H&N35, -C30 on the first visit. Patients were treated with PPI (Ilaprazole20 mg/day) on their visits at 4, 8, and 12 weeks. RSI and RFS were measured at each visit andHR-QoL was reevaluated on the last visit. Results Ninety-five patients completed the 3-months follow-up and were enrolled in thisstudy. Female : male ratio was 71:24 and the mean age was 57.0±11.9 (27-80). The initial RSIand RFS were 16.3±8.8 and 12.6±2.9, respectively, but were changed to 11.1±9.7 and 9.7±2.6(p<0.001 in both) at 12 weeks after the treatment. Global health status/QoL, speech problem,dry mouth, and coughing were significantly improved. Conclusion PPI administration is effective in treating LPRD, where effects begin to appear at4 weeks after treatment. HR-QoL was also improved in patients who have RSI improvement.

Abstract

Background and Objectives Several studies have assessed the impact of laryngopharyngealreflux disease (LPRD) on the health-related quality of life (HR-QoL), showing significantimpairment of HR-QoL. This study aims to assess the impact of proton pump inhibitor (PPI)treatment of LPRDs to enhance HR-QoL. Subjects and Method We prospectively collected data from LPRD patients from April2017 to July 2019. Patients who have reflux symptom index (RSI) of ≥13 or reflux findingscore (RFS) of ≥7 were enrolled in this study. We assessed HR-QoL using a questionnairewith EORTC QLQ-H&N35, -C30 on the first visit. Patients were treated with PPI (Ilaprazole20 mg/day) on their visits at 4, 8, and 12 weeks. RSI and RFS were measured at each visit andHR-QoL was reevaluated on the last visit. Results Ninety-five patients completed the 3-months follow-up and were enrolled in thisstudy. Female : male ratio was 71:24 and the mean age was 57.0±11.9 (27-80). The initial RSIand RFS were 16.3±8.8 and 12.6±2.9, respectively, but were changed to 11.1±9.7 and 9.7±2.6(p<0.001 in both) at 12 weeks after the treatment. Global health status/QoL, speech problem,dry mouth, and coughing were significantly improved. Conclusion PPI administration is effective in treating LPRD, where effects begin to appear at4 weeks after treatment. HR-QoL was also improved in patients who have RSI improvement.

참고문헌 (23)

  1. Koufman JA, "Laryngopharyngeal reflux: Position statement of the committee on speech, voice, and swallowing disorders of the American Academy of OtolaryngologyHead and Neck Surgery", Otolaryngol Head Neck Surg, 127(1), pp.32~35 (2002)
  2. Belafsky PC, "The validity and reliability of the reflux finding score (RFS)", Laryngoscope, 111(8), pp.1313~1317 (2001)
  3. Belafsky PC, "Validity and reliability of the reflux symptom index (RSI)", J Voice, 16(2), pp.274~277 (2002)
  4. 정영호, "건강검진 수진자들에서의 역류성 인후두염의 증상지수 및소견점수의 분포 양상과 위내시경 소견과의 연관성 분석", 대한이비인후-두경부외과학회지, 50(5), pp.431~437 (2007), 대한이비인후과학회
  5. Koufman JA, "The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury", Laryngoscope, 101(4 Pt 2 Suppl 53), pp.1~78 (1991)
  6. Carrau RL, "The impact of laryngopharyngeal reflux on patient-reported quality of life", Laryngoscope, 114(4), pp.670~674 (2004)
  7. Carrau RL, "Validation of a quality-of-life instrument for laryngopharyngeal reflux", Arch Otolaryngol Head Neck Surg, 131(4), pp.315~320 (2005)
  8. Gong EJ, "Quality of life, patient satisfaction, and disease burden in patients with gastroesophageal reflux disease with or without laryngopharyngeal reflux symptoms", J Gastroenterol Hepatol, 32(7), pp.1336~1340 (2017)
  9. Lee JS, "Changes in the quality of life of patients with laryngopharyngeal reflux after treatment", J Voice, 28(4), pp.487~491 (2014)
  10. Lenderking WR, "The clinical characteristics and impact of laryngopharyngeal reflux disease on health-related quality of life", Value Health, 6(5), pp.560~565 (2003)
  11. Postma GN, "Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease", Ann Otol Rhinol Laryngol, 110(12), pp.1114~1116 (2001)
  12. Belafsky PC, "Symptoms and findings of laryngopharyngeal reflux", Ear Nose Throat J, 81(9Suppl 2), pp.10~13 (2002)
  13. Book DT, "Perspectives in laryngopharyngeal reflux: An international survey", Laryngoscope, 112(8 Pt 1), pp.1399~1406 (2002)
  14. Noordzij JP, "Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis", Laryngoscope, 112(12), pp.2192~2195 (2002)
  15. Siupsinskiene N, "Quality of life in laryngopharyngeal reflux patients", Laryngoscope, 117(3), pp.480~484 (2007)
  16. Cheung TK, "Quality of life in patients with laryngopharyngeal reflux", Digestion, 79(1), pp.52~57 (2009)
  17. 이윤재, "인후두 역류증의 약물요법에 적절한 약제 및 치료기간의 선택", 대한이비인후-두경부외과학회지, 57(10), pp.698~702 (2014), 대한이비인후과학회[DOI]
  18. Yang J, "Treating laryngopharyngeal reflux: Evaluation of an anti-reflux program with comparison to medications", Am J Otolaryngol, 39(1), pp.50~55 (2018)
  19. Ford CN, "Evaluation and management of laryngopharyngeal reflux", JAMA, 294(12), pp.1534~1540 (2005)
  20. 정만기, "인후두 역류증에 대한 초치료로서 양성자 펌프 억제제4주 단기 치료의 효과", 대한이비인후-두경부외과학회지, 48(6), pp.796~800 (2005), 대한이비인후과학회
  21. Park W, "Laryngopharyngeal reflux: Prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response", Laryngoscope, 115(7), pp.1230~1238 (2005)
  22. Reichel O, "Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux", Otolaryngol Head Neck Surg, 139(3), pp.414~420 (2008)
  23. Jin bJ, "Change of acoustic parameters before and after treatment in laryngopharyngeal reflux patients", Laryngoscope, 118(5), pp.938~941 (2008)

관련 논문AI추천

양성자 펌프 억제제가 인후두 역류증과 동반된 만성 비부비동염에 미치는 영향강민혁, 김지환, 이동욱, 정한진대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2019 · 제62권 제3호인후두역류증이 의심되는 환자에서 비디오투시법의 역할곽민영, 유광규, 이승주대한이비인후과학회 부산,울산,경남 지부회 · 임상이비인후과2014 · 제25권 제2호Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux남순열, 박영학, 손영익, 신명희대한이비인후과학회 · Clinical and Experimental Otorhinolaryngology2012 · 제5권 제1호인후두 역류증에 대한 양성자 펌프 억제제 단기 치료가 음성에 미치는 영향김창용, 신향애, 이자현, 장정현, 정세원, 최현승대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2014 · 제57권 제10호인후두 역류증의 약물요법에 적절한 약제 및 치료기간의 선택태경, 곽민규, 송창면, 엄지훈, 이윤재, 지용배대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2014 · 제57권 제10호인후두 역류질환에서 24시간 이중 탐침 산도 검사와 Reflux Finding Score, Reflux Symptom Index의 연관성태경, 송창면, 오재호, 정진혁, 지용배, 진봉준대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2013 · 제56권 제11호

이 간행물의 다른 논문 (6건)

코로나바이러스감염증-19에서의 후각장애한두희, 김준곤pp. 491-496Comparison among Three Different Steroid Therapies for Idiopathic Sudden Sensorineural Hearing Loss정다정, 유명훈, 이지훈, 이규엽pp. 497-504Validation of Simultaneous Endoscopic Sinus Surgery and Transsphenoidal Surgery in Patients with Chronic Rhinosinusitis and Pituitary Tumors허경욱, 박성국, 이동후, 박찬현, 박성율, 김도훈, 장준혁, 김우진pp. 505-510성대 용종 환자에서 경윤상 갑상막 접근을 통한 성대 내 스테로이드 주입술의 효과진성민, 노승호, 이상혁, 김선우, 이진, 남우주pp. 511-516외이도의 고립성 섬유종 1예안윤숙, 강주창, 권계원, 신규하pp. 523-527
원문 보기